Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Oct;70(10):7219–7223. doi: 10.1128/jvi.70.10.7219-7223.1996

Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2.

T Mizutani 1, N Kato 1, S Saito 1, M Ikeda 1, K Sugiyama 1, K Shimotohno 1
PMCID: PMC190776  PMID: 8794370

Abstract

We recently found that a human T-cell leukemia virus type 1-infected cell line, MT-2, could support the replication of hepatitis C virus (HCV) (N. Kato, T. Nakazawa, T. Mizutani, and K. Shimotohno, Biochem. Biophys. Res. Commun. 206:863-869, 1995). In order to develop a culture system in which HCV replicates more efficiently, we examined the efficiency of HCV replication in cloned MT-2 cell lines by the limiting dilution method. Consequently, we obtained five clones in which intracellular positive-stranded HCV RNA could be detected until at least 21 days postinoculation (p.i.), as opposed to 15 days p.i. in uncloned MT-2 cells. MT-2C, one of the five clones which supported HCV replication up to 30 days p.i., was used for further characterization of HCV replication. Semiquantitative analysis of HCV by PCR revealed that RNA synthesis in infected cells increased after inoculation, reached a maximum level at 4 days p.i., and maintained this level until at least 11 days p.i. The 5' untranslated region of negative-stranded HCV RNA was also detected in the infected cells by two different methods with strand specificity. These results suggest that HCV replicated and multiplied in the MT-2C cells. HCV-infected MT-2C cells that were treated with antibiotics, such as G418 and hygromycin B, sustained HCV RNA for a longer period than did untreated cells. We demonstrated inhibitory effects on HCV replication by an antisense oligonucleotide complementary to the HCV core encoding region and by interferon-alpha. Furthermore, cell-free viral transmission was demonstrated by this culture system. These results suggest that our cell culture system will be useful for studying the mechanism of HCV replication, for screening antiviral agents, and for developing HCV vaccines.

Full Text

The Full Text of this article is available as a PDF (273.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  2. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2451–2455. doi: 10.1073/pnas.88.6.2451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colman A. Antisense strategies in cell and developmental biology. J Cell Sci. 1990 Nov;97(Pt 3):399–409. doi: 10.1242/jcs.97.3.399. [DOI] [PubMed] [Google Scholar]
  4. Cribier B., Schmitt C., Bingen A., Kirn A., Keller F. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J Gen Virol. 1995 Oct;76(Pt 10):2485–2491. doi: 10.1099/0022-1317-76-10-2485. [DOI] [PubMed] [Google Scholar]
  5. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993 Mar;67(3):1385–1395. doi: 10.1128/jvi.67.3.1385-1395.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gunji T., Kato N., Hijikata M., Hayashi K., Saitoh S., Shimotohno K. Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch Virol. 1994;134(3-4):293–302. doi: 10.1007/BF01310568. [DOI] [PubMed] [Google Scholar]
  7. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun. 1991 Feb 28;175(1):220–228. doi: 10.1016/s0006-291x(05)81223-9. [DOI] [PubMed] [Google Scholar]
  8. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5547–5551. doi: 10.1073/pnas.88.13.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993 Aug;67(8):4665–4675. doi: 10.1128/jvi.67.8.4665-4675.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., Shimotohno K. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10773–10777. doi: 10.1073/pnas.90.22.10773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaito M., Watanabe S., Tsukiyama-Kohara K., Yamaguchi K., Kobayashi Y., Konishi M., Yokoi M., Ishida S., Suzuki S., Kohara M. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol. 1994 Jul;75(Pt 7):1755–1760. doi: 10.1099/0022-1317-75-7-1755. [DOI] [PubMed] [Google Scholar]
  12. Kamihira S., Yamada Y., Sohda H., Atogami S., Tomonaga M., Egawa S., Fujii M., Chifu K. Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma. Cancer Detect Prev. 1994;18(5):329–334. [PubMed] [Google Scholar]
  13. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9524–9528. doi: 10.1073/pnas.87.24.9524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kato N., Nakazawa T., Mizutani T., Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun. 1995 Jan 26;206(3):863–869. doi: 10.1006/bbrc.1995.1123. [DOI] [PubMed] [Google Scholar]
  15. Kato N., Ootsuyama Y., Sekiya H., Ohkoshi S., Nakazawa T., Hijikata M., Shimotohno K. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol. 1994 Aug;68(8):4776–4784. doi: 10.1128/jvi.68.8.4776-4784.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kato N., Ootsuyama Y., Tanaka T., Nakagawa M., Nakazawa T., Muraiso K., Ohkoshi S., Hijikata M., Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 1992 Feb;22(2):107–123. doi: 10.1016/0168-1702(92)90038-b. [DOI] [PubMed] [Google Scholar]
  17. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 1993 Jul;67(7):3923–3930. doi: 10.1128/jvi.67.7.3923-3930.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  19. Lanford R. E., Chavez D., Chisari F. V., Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol. 1995 Dec;69(12):8079–8083. doi: 10.1128/jvi.69.12.8079-8083.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lanford R. E., Sureau C., Jacob J. R., White R., Fuerst T. R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 1994 Aug 1;202(2):606–614. doi: 10.1006/viro.1994.1381. [DOI] [PubMed] [Google Scholar]
  21. Lin C., Lindenbach B. D., Prágai B. M., McCourt D. W., Rice C. M. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol. 1994 Aug;68(8):5063–5073. doi: 10.1128/jvi.68.8.5063-5073.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Manabe S., Fuke I., Tanishita O., Kaji C., Gomi Y., Yoshida S., Mori C., Takamizawa A., Yosida I., Okayama H. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology. 1994 Feb;198(2):636–644. doi: 10.1006/viro.1994.1075. [DOI] [PubMed] [Google Scholar]
  23. Mizushima H., Hijikata M., Asabe S., Hirota M., Kimura K., Shimotohno K. Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol. 1994 Oct;68(10):6215–6222. doi: 10.1128/jvi.68.10.6215-6222.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mizutani T., Kato N., Hirota M., Sugiyama K., Murakami A., Shimotohno K. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Biochem Biophys Res Commun. 1995 Jul 26;212(3):906–911. doi: 10.1006/bbrc.1995.2055. [DOI] [PubMed] [Google Scholar]
  25. Müller H. M., Pfaff E., Goeser T., Kallinowski B., Solbach C., Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol. 1993 Apr;74(Pt 4):669–676. doi: 10.1099/0022-1317-74-4-669. [DOI] [PubMed] [Google Scholar]
  26. Nakazawa T., Kato N., Ootsuyama Y., Sekiya H., Fujioka T., Shibuya A., Shimotohno K. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. Int J Cancer. 1994 Jan 15;56(2):204–207. doi: 10.1002/ijc.2910560210. [DOI] [PubMed] [Google Scholar]
  27. Okayama A., Maruyama T., Tachibana N., Hayashi K., Kitamura T., Mueller N., Tsubouchi H. Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus. Jpn J Cancer Res. 1995 Jan;86(1):1–4. doi: 10.1111/j.1349-7006.1995.tb02979.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Qian C., Camps J., Maluenda M. D., Civeira M. P., Prieto J. Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy. J Hepatol. 1992 Nov;16(3):380–383. doi: 10.1016/s0168-8278(05)80674-9. [DOI] [PubMed] [Google Scholar]
  29. Saleh M. G., Tibbs C. J., Koskinas J., Pereira L. M., Bomford A. B., Portmann B. C., McFarlane I. G., Williams R. Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology. 1994 Dec;20(6):1399–1404. doi: 10.1002/hep.1840200604. [DOI] [PubMed] [Google Scholar]
  30. Sekiya H., Kato N., Ootsuyama Y., Nakazawa T., Yamauchi K., Shimotohno K. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer. 1994 Jun 1;57(5):664–670. doi: 10.1002/ijc.2910570509. [DOI] [PubMed] [Google Scholar]
  31. Selby M. J., Choo Q. L., Berger K., Kuo G., Glazer E., Eckart M., Lee C., Chien D., Kuo C., Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol. 1993 Jun;74(Pt 6):1103–1113. doi: 10.1099/0022-1317-74-6-1103. [DOI] [PubMed] [Google Scholar]
  32. Shimizu Y. K., Iwamoto A., Hijikata M., Purcell R. H., Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5477–5481. doi: 10.1073/pnas.89.12.5477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shimizu Y. K., Purcell R. H., Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6037–6041. doi: 10.1073/pnas.90.13.6037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shimizu Y. K., Yoshikura H. Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons. J Virol. 1994 Dec;68(12):8406–8408. doi: 10.1128/jvi.68.12.8406-8408.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991 Mar;65(3):1105–1113. doi: 10.1128/jvi.65.3.1105-1113.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tinè F., Magrin S., Craxì A., Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol. 1991 Sep;13(2):192–199. doi: 10.1016/0168-8278(91)90814-r. [DOI] [PubMed] [Google Scholar]
  37. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 1993 Jul;67(7):4017–4026. doi: 10.1128/jvi.67.7.4017-4026.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zibert A., Schreier E., Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 1995 Apr 20;208(2):653–661. doi: 10.1006/viro.1995.1196. [DOI] [PubMed] [Google Scholar]
  39. Zignego A. L., Macchia D., Monti M., Thiers V., Mazzetti M., Foschi M., Maggi E., Romagnani S., Gentilini P., Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992 Jul;15(3):382–386. doi: 10.1016/0168-8278(92)90073-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES